A randomized study found lower postoperative inflammatory markers with dexmedetomidine than with midazolam. The biomarker findings did not establish that inflammation mediated every anxiety difference.
One hundred twenty children were assigned to dexmedetomidine, midazolam, or saline before hernia surgery. Several postoperative inflammatory measures were lower in the dexmedetomidine group than in the midazolam group.
Postoperative anxiety scores were positively correlated with inflammatory markers. Correlation between these endpoints was part of the interpretation rather than proof of a causal pathway.
Inflammatory markers were measured at the end of surgery, without preoperative baseline measurements or a full postoperative time course. That limits conclusions about individual changes and temporal relationships.
The findings concern selected children and a specific operation and regimen. They do not establish that midazolam causes harmful inflammation or that lower markers necessarily produce better long-term outcomes. Retain randomization, measurement timing, and the separate clinical and biochemical endpoints when discussing the study.
Original analysis of the supplied journal article, identified as PMC8251734.